cryopyrinassociated periodic syndrome caps group rare heterogeneous autoinflammatory disease characterized interleukin systemic inflammation clinical symptoms involving skin joints central nervous system eyes encompasses spectrum three clinically overlapping autoinflammatory syndromes including familial cold autoinflammatory syndrome fcas formerly termed familial coldinduced urticaria syndrome mws neonatalonset multisystem inflammatory disease nomid also called chronic infantile neurologic cutaneous articular syndrome cinca originally thought distinct entities fact share single genetic mutation pathogenic pathway keratoendotheliitis fugax hereditaria autoinflammatory symptoms affect anterior segment eye syndromes within caps overlap clinically patients may features one disorder retrospective cohort caps patients systemic involvement prevalent clinical features fever cases often concurrent constitutional symptoms fatigue malaise mood disorders failure thrive skin rash either urticarial maculopapular rash cases especially cold exposure musculoskeletal involvement myalgia arthralgia andor arthritis less commonly joint contracture patellar overgrowth bone deformity bone erosion andor osteolytic lesion cases less common features included ophthalmological involvement conjunctivitis andor uveitis less commonly optic nerve atrophy cataract glaucoma impaired vision cases neurosensory hearing loss cases neurological involvement morning headache papilloedema andor meningitis less commonly seizure hydrocephalus intellectual disability cases aa amyloidosis casescitation needed keratoendotheliitis fugax hereditaria systemic symptoms reported whereas patients experience periodical transient inflammation corneal endothelium stroma leading short term blurring vision repeated attacks central corneal stromal opacities age onset typically infancy early childhood cases caps chronic phenotype symptoms present almost daily whereas remaining patients experienced acute episodes patients reported family history caps previous studies confirm symptoms although exact reported rates cryopyrinassociated periodic syndromes associated gainoffunction missense mutation exon gene encoding cryopyrin major component interleukin keratoendotheliitis fugax hereditaria mutation occurs exon intracellular formation interleukin inflammasome leads activation potent proinflammatory cytokines interleukin cascade involving caspase inflammasome may also released activated macrophages amplifying cytokine production mutation leads aberrant formation inflammasome subsequent unregulated production interleukin needed heterogenous mutations identified reports suggest rare mutations frequently associated severe mutations associated distinct phenotypes probably reflecting differential impact mutation activity inflammasome context individual genetic inheritance disorders autosomal dominant variable penetrancecitation needed caps extremely rare broad clinical presentation difficult diagnose significant delay exists symptom onset definitive currently clinical diagnostic criteria caps based solely clinical presentation instead diagnosis made genetic testing mutations acute phase reactants white blood cell count usually persistently elevated aspecific capscitation needed since interleukin plays central role pathogenesis disease therapy typically targets cytokine form monoclonal antibodies binding proteinstraps interleukin receptor antagonists therapies generally effective alleviating symptoms substantially reducing levels inflammatory indices case reports suggest receptor antibody may also effective httpsenwikipediaorgwikicryopyrinassociatedperiodicsyndrome